机译:生存的寿命质量作为生存的预后指标:来自加拿大癌症试验组临床试验的个体患者数据的汇总分析
Quality of Life Department European Organization for Research and Treatment of CancerBrussels;
Epidemiological Methods Section Surveillance and Response Support Unit European Center for;
Quality of Life Department European Organization for Research and Treatment of CancerBrussels;
Princess Margaret Cancer CentreUniversity of TorontoToronto Ontario Canada;
Canadian Cancer Trials GroupKingston Ontario Canada;
Quality of Life Department European Organization for Research and Treatment of CancerBrussels;
Canadian Cancer Trials GroupKingston Ontario Canada;
Canadian Cancer Trials GroupKingston Ontario Canada;
Canadian Cancer Trials GroupKingston Ontario Canada;
Child and Adolescent PsychiatryUniversity MagdeburgMagdeburg Germany;
Obstetrics and GynecologyMedical University GrazGraz Austria;
Center for Health ManagementDuke University School of MedicineDurham North Carolina;
Department of NeurologyLeiden University Medical CenterLeiden the Netherlands;
Department of NeurologyLeiden University Medical CenterLeiden the Netherlands;
Department of NeurologyLeiden University Medical CenterLeiden the Netherlands;
Quality of Life Department European Organization for Research and Treatment of CancerBrussels;
cancer clinical trial; health‐related quality of life; overall survival; pooled analysis; prognostic factor;
机译:生存的寿命质量作为生存的预后指标:来自加拿大癌症试验组临床试验的个体患者数据的汇总分析
机译:与胶质瘤患者的整体存活和无进展生存期的预后性生活质量的附加值额增加:基于来自随机对照试验的个体患者数据的META分析
机译:来自国家临床试验网络临床临床试验对老年患者的有限阶段小细胞肺癌的同时调节疗法的个体患者数据的汇总分析
机译:癌症临床试验群体真正代表癌症患者吗?对癌症基因组阿特拉斯公开临床试验的比较
机译:通过比较不同统计方法对晚期乳腺癌患者的临床试验的生活质量数据进行分析。
机译:QLIF-27。与生活质量相关的生活质量(HRQoL)的附加值它是胶质瘤患者总体生存和无进展生存的预后指标:一种基于来自随机对照的个体患者数据的meta分析
机译:生存的预后质量:来自加拿大癌症试验组临床试验的个体患者数据的汇总分析